wilms-tumor

Wilms tumor survivors had nearly threefold higher metabolic syndrome prevalence

Metabolic syndrome affected 18.8% of Wilms tumor survivors versus 7.3% of matched controls, with abdominal radiotherapy emerging as an important risk factor.